<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55402">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01984632</url>
  </required_header>
  <id_info>
    <org_study_id>MYO04</org_study_id>
    <nct_id>NCT01984632</nct_id>
  </id_info>
  <brief_title>Barbed Suture in Single-port Laparoscopic Myomectomy</brief_title>
  <official_title>Single-port Laparoscopic Myomectomy Using Barbed Suture Versus Multi-port One: a Multi-center Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHA University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHA University</source>
  <oversight_info>
    <authority>South Korea: Institutional Review Board</authority>
    <authority>South Korea: Korea Food and Drug Administration (KFDA)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to test our hypothesis that the use of unidirectional knotless
      barbed suture in single-port laparoscopic myomectomy could facilitate the suture of uterine
      wall defect after myoma enucleation as multi-port laparoscopic myomectomy did.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators plan to perform a multi-center randomized clinical trial on women
      scheduled for laparoscopic myomectomy. All women will get the same preoperative and
      postoperative care. Women will be assigned by chance to one of two groups: one group will
      receive single-port laparoscopic myomectomy using V-Loc™ suture material (study group). The
      other group will receive conventional multi-port laparoscopic myomectomy using V-Loc™ suture
      material (control group). The investigators will collect information on suturing time and
      complications related to surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Suturing time</measure>
    <time_frame>Intra-operative</time_frame>
    <safety_issue>No</safety_issue>
    <description>the time duration for the suture of uterine wall defect after myoma enucleation during laparoscopic myomectomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cosmetic satisfaction</measure>
    <time_frame>Post-surgery 1 month and 3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will compare patient's cosmetic satisfaction through self-reported questionnaire (Body image Questionnaire).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Uterine Myoma</condition>
  <arm_group>
    <arm_group_label>Single-port laparoscopic myomectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>We will use barbed suture (V-Loc) under intervention of single-port laparoscopic myomectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multi-port laparoscopic myomectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>We will use barbed suture(V-Loc) under intervention of multi-port laparoscopic myomectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single-port laparoscopic myomectomy</intervention_name>
    <description>The aim of this study is to compare single-port laparoscopic myomectomy using barbed suture (experimental group) with multi-port laparoscopic myomectomy using barbed suture (control group) in terms of operative time (esp. suturing time).</description>
    <arm_group_label>Single-port laparoscopic myomectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Multi-port laparoscopic myomectomy</intervention_name>
    <description>The aim of this study is to compare single-port laparoscopic myomectomy using barbed suture (experimental group) with multi-port laparoscopic myomectomy using barbed suture(control group) in terms of operative time (esp. suturing time).</description>
    <arm_group_label>Multi-port laparoscopic myomectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 55 years

          -  Image-confirmed uterine myoma

          -  Number of myoma ≤2 and largest size ≤10cm

          -  Women who were scheduled to have laparoscopic myomectomy

          -  Appropriate medical status for laparoscopic surgery (American Society of
             Anesthesiologists Physical Status classification 1 or 2)

        Exclusion Criteria:

          -  Women with pedunculated subserosal myoma or submucosal myoma

          -  Women undergoing concomitant complex surgical procedures at the time of laparoscopic
             myomectomy such as severe adhesiolysis or resection for severe endometriosis

          -  Women with any suggestion of malignant uterine or adnexal diseases

          -  Women with diabetics, malignancy, or malnutrition, which can affect wound healing

          -  Women having major medical comorbidity or psychiatric illness, which could affect
             follow-up and/or compliance

          -  Women who refuse to participate or give consent to the procedures
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taejong Song, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHA Gangnam Medical Center, CHA university, Seoul, Republic of Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Taejong Song</last_name>
    <phone>+82-10-4035-8405</phone>
    <email>taejong.song@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Health Insurance Service Ilsan Hospital</name>
      <address>
        <city>Goyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>San-Hui Lee, Professor</last_name>
      <phone>+82-10-9948-4459</phone>
      <email>sanaram@naver.com</email>
    </contact>
    <investigator>
      <last_name>San-Hui Lee, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHA Gangnam Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taejong Song, Professor</last_name>
      <phone>+82-10-4035-8405</phone>
      <email>taejong.song@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Taejong Song, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae-Joong Kim, Professor</last_name>
      <phone>+82-10-9933-3547</phone>
      <email>tj28.kim@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Tae-Joong Kim, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Woo Young Kim, Professor</last_name>
      <phone>+82-10-5343-3481</phone>
      <email>obgykim@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Woo Young Kim, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 21, 2013</lastchanged_date>
  <firstreceived_date>November 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CHA University</investigator_affiliation>
    <investigator_full_name>Taejong Song</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Myoma</mesh_term>
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
